Therapy Areas: Oncology
Circio partners with Acuitas to evaluate in vivo CAR-T cell therapy technology
15 April 2026 - Biotechnology company Circio Holding ASA (OSE:CRNA) announced on Wednesday that it has entered into an evaluation agreement with Canadian biotechnology company Acuitas Therapeutics to ...
Poolbeg Pharma secures MHRA approval for POLB 001 trial as US research highlights multi-billion dollar potential
15 April 2026 - Biopharmaceutical company Poolbeg Pharma plc (AIM: POLB) announced on Wednesday that it has received Clinical Trial Authorisation from the UK Medicines and Healthcare products Regulato...
Asgard Therapeutics appoints chief medical officer
15 April 2026 - Asgard Therapeutics, a Swedish biotech company focused on in vivo direct cell reprogramming for cancer immunotherapy, announced on Tuesday the appointment of Prof Dr Wolfram Brugger as...
Mestag Therapeutics to present targeted LTBR agonist MST-0312 at AACR Annual Meeting
15 April 2026 - Mestag Therapeutics, a UK-based biotech company using fibroblast immunology to develop treatments for patients with cancer and inflammatory disease, announced on Tuesday that it has be...
Senhwa Biosciences secures up to TWD500m funding for AI-driven drug development
15 April 2026 - Taiwan-based clinical-stage biopharmaceutical company Senhwa Biosciences Inc (TPEx:6492) announced on Tuesday the signing of a Memorandum of Understanding (MOU) with GEM YIELD BAHAMAS ...
CrossBridge Bio to be acquired by Eli Lilly
14 April 2026 - CrossBridge Bio Inc, a pre-clinical biotechnology company developing next-generation dual-payload antibody-drug conjugates (ADCs), announced on Tuesday that it has entered into a defin...